Ultra Nasdaq Biotechnology 2X ETF (BIB)

$48.20 0.19 (0.40%)

16:15 EDT BIB Stock Quote Delayed 30 Minutes

Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich

By Ian Cooper, InvestorPlace Contributor Mar 25, 2024

Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom.

3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024

The 7 Best ETFs to Buy to Cover 2023’s Biggest Investing Opportunities

The 7 Hottest Biotech Stocks to Own in 2023 and Beyond

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 16,296

Day's Range $47.20 - $48.68

52-Week Range $40.10 - $62.45

Dividend & Yield $0.02 (0.04%)

BIB Stock Predictions, Articles, and Ultra Nasdaq Biotechnology 2X ETF News

From InvestorPlace
From the Web

3 Top Drug Stocks to Own In 2020

By Ian Cooper, InvestorPlace Contributor Jan 3, 2020

Some of the biggest catalysts for future growth in drug stocks include the millions of retiring baby boomers, and new innovative treatments for a variety of medical issues.

Can Biotech Stocks Bounce Back?

By Hilary Kramer, Editor, GameChangers Feb 19, 2016

The biotech sector has been under pressure for months, and things aren't likely to improve anytime soon. Here's what's ailing biotech stocks.

Be Careful Before Loving Leveraged Biotech ETFs

By Todd Shriber, InvestorPlace Contributor Oct 6, 2015

The new crop of triple-leveraged biotech ETFs have had staggering returns (and losses), serving as a reminder that not all investors should be involved with leveraged ETFs.